Searched for
COREX PHENSEDYL
Govt challenges revocation of FDC drug ban in Supreme CourtThe petition comes almost two months after the Delhi HC on December 2 set aside the govt notification that had banned hundreds of fixed dos...- Delhi High Court quashes government ban on over 300 medicines like Corex, SaridonThe brands included D'Cold Total, Corex cough syrup, and Vicks Action 500, among others.
- Delhi High Court verdict on combination drugs ban likely todayEndlaw is expected to give his verdict even as the government has submitted a petition to transfer all FDC cases across the country to the ...
- Many prohibited drugs available in markets: Ananth KumarKumar said in Lok Sabha that these 439 drugs, including 344 fixed dose combinations, were banned after examination of the samples of the me...
- Bihar to ban supply of medicinal drugs with alcohol contentBihar government is contemplating to restrict the supply of all medicinal drugs with have alcohol contents. In principal it has been decide...
- Delhi High Court grants interim stay on ban of Abbott’s PhensedylAbbott got a stay on five products in all, including codeine-based formulations and another for management of epilepsy.
- P&G catches cold as Vicks goes off the shelf; Pfizer, Abbott in pain tooCompanies such as Abbott India, Macleods Pharma, Pfizer, Alkem Labs and IPCA Labs are among the companies that are likely to be hurt by the...
- More than 500 drugs may face banHealth ministry, which banned 344 fixed-dose combinations including cough syrups like Phensedyl, Corex and Benadryl, is evaluating a list o...
- P&G stops selling Vicks Action 500 Extra in India after banP&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.
- Shares of Pfizer plunge on the BSE following Corex banHowever, Abbott India that sells another popular cough syrup Phensedyl, also in the list of banned drugs, closed marginally higher.
- Pfizer, Abbott shares tank after ban on Corex, Phensedyl and 327 other drugsAbbott India shares fell 1.98 per cent to hit a low of Rs 4,755 after ban on its Phensedyl syrup. Abbott is reviewing the notification, the...
- Pfizer, Abbott stop sale of cough syrups in India post banCorex is a combination of chlopheniramine maleate and codeine syrup - one of 344 drug combinations India banned over the weekend.
- Drug retail sales up 18% in 2010 as cos take rural roadsSales in the domestic drug retail market rose a healthy 18.36% during 2010, making India an attractive destination for foreign players.
- Drug market grows 20% in H1; foreign firms tighten holdA series of buyouts by foreign heavy weights, including Ranbaxy and Piramal Healthcare has resulted in foreign MNCs taking three slots amon...
- Piramal Healthcare rethinks plan to set up new drug unitPiramal Healthcare is reviewing its plans to set up a new unit to make codeine, the basic chemical used to produce best-selling cough syrup...
- Cipla beats Ranbaxy, tops sales in SeptemberCipla's sales grew 15.3% from last month, garnering 4.92% while Ranbaxy sales grew just 0.9% with a mkt share of 4.81%. Drug cos in price w...
- Ayurvedic brand Liv-52, India's top selling drugFor a sales index that’s perpetually skewed towards cough syrups, which is often misused as a cheap substitute for alcohol, and pain killer...
- Pfizer, Nicholas Piramal hit by codeine shortageHit by the shortage of raw material codeine, India’s highest selling drug (in value) Pfizer’s cough syrup Corex has slipped to the eighth s...
- Pfizer, NPIL abused by drug addictsPfizer's Corex and Nicholas Piramal's Phensedyl give a 'kick' to drug addicts, say experts.
- Shrinking pie forces pharma to build brandsIndian pharma companies which paid little focus on building brands will soon have to do so.
Load More
